|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn646758792 |
003 |
OCoLC |
005 |
20231117033252.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
751101s1996 ne a ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d UBY
|d OCLCQ
|d OPELS
|d IDEBK
|d OCLCQ
|d OCLCF
|d OCLCQ
|d DEBBG
|d D6H
|d LEAUB
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 505106288
|a 742292169
|a 815687683
|a 823116919
|
020 |
|
|
|a 0444823107
|q (electronic bk.)
|
020 |
|
|
|a 9780444823106
|q (electronic bk.)
|
020 |
|
|
|a 1281759872
|
020 |
|
|
|a 9781281759870
|
035 |
|
|
|a (OCoLC)646758792
|z (OCoLC)505106288
|z (OCoLC)742292169
|z (OCoLC)815687683
|z (OCoLC)823116919
|
050 |
|
4 |
|a RS400
|b .P7633 1996eb
|
072 |
|
7 |
|a MJP
|2 bicssc
|
082 |
0 |
4 |
|a 615.1/9
|2 23
|
245 |
0 |
0 |
|a Progress in medicinal chemistry.
|n Volume 33 /
|c editors, G.P. Ellis and D.K. Luscombe.
|
260 |
|
|
|a Amsterdam ;
|a New York :
|b Elsevier,
|c 1996.
|
300 |
|
|
|a 1 online resource (viii, 397 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Progress in medicinal chemistry ;
|v v. 33
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a Seven topics of general interest to medicinal chemists, microbiologists, pharmacologists and clinicians are reviewed. The subjects examined are: phosphodiesterase type IV inhibitors and therapeutic potential in the treatment of asthma; the mode of action and biosynthesis of the immunosuppressant cyclosporins; the present status of carbapenems in the treatment of bacterial infection; the treatment of breast cancer by inhibiting aromatase; a new class of potentially useful antipsychotics; and the role of protein tyrosine kinases and their inhibition of cell multiplication by a wide variety of compounds.
|
650 |
|
0 |
|a Chemistry.
|
650 |
|
0 |
|a Pharmaceutical chemistry.
|
650 |
|
2 |
|a Chemistry
|0 (DNLM)D002621
|
650 |
|
2 |
|a Chemistry, Pharmaceutical
|0 (DNLM)D002626
|
650 |
|
6 |
|a Chimie.
|0 (CaQQLa)201-0006068
|
650 |
|
6 |
|a Chimie pharmaceutique.
|0 (CaQQLa)201-0028674
|
650 |
|
7 |
|a chemistry.
|2 aat
|0 (CStmoGRI)aat300054537
|
650 |
|
7 |
|a Chemistry
|2 fast
|0 (OCoLC)fst00853344
|
650 |
|
7 |
|a Pharmaceutical chemistry
|2 fast
|0 (OCoLC)fst01060115
|
700 |
1 |
|
|a Ellis, G. P.
|q (Gwynn Pennant)
|
700 |
1 |
|
|a Luscombe, D. K.
|q (David K.)
|
776 |
0 |
8 |
|i Print version:
|t Progress in medicinal chemistry. Volume 33.
|d Amsterdam ; New York : Elsevier, 1996
|w (DLC) 62002712
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780444823106
|z Texto completo
|